SLC25A5 and Alzheimer disease: As a highly expressed solute carrier protein in the cortex and the hippocampus, the increased mean precursor intensity of peptide from SLC25A5 was observed in AD, and the mutation of this gene was recognized as an important risk factor for a facial dysmorphism and seizures characterized by intellectual disability (ID) (11, 29).